Top story
November 12, 2026
Press Release
AIML Subsidiary NeuralCloud Signs Agreement with Etisense to Advance Animal-Model ECG Labeling with MaxYield™
Read the announcement
Featured this week
The newsroom pulls every public-facing channel — press releases, blog posts, the CEO's Substack, our YouTube channel, and shareholder newsletters — into a single feed.
November 12, 2026
AIML Subsidiary NeuralCloud Signs Agreement with MyCor360+ to Integrate MaxYield™ into Next-Generation Cardiac Monitoring Device
Collaboration to Combine AI-Powered ECG Signal Processing with New Cardiac Monitoring Hardware for Clinical Applications
PRESS RELEASE
October 29, 2026
AIML Subsidiary NeuralCloud Signs Agreement with Etisense to Advance Animal-Model ECG Labeling with MaxYield™
Press Releases
Cross-posted to SEDAR+, the CSE listing page, and our investor email list within minutes of publication. The most-recent six are below.
November 12, 2026
AIML Subsidiary NeuralCloud Signs Agreement with MyCor360+ to Integrate MaxYield™ into Next-Generation Cardiac Monitoring Device
October 29, 2026
AIML Subsidiary NeuralCloud Signs Agreement with Etisense to Advance Animal-Model ECG Labeling with MaxYield™
October 2, 2026
AI/ML Innovations Appoints Lynn Chapman as Chief Financial Officer and Announces Share Issuance for Debt Settlement
October 1, 2026
AIML Subsidiary NeuralCloud Signs Binding Commercial Term Sheet with VetMed Consultants for MaxYield™ ECG Services
September 29, 2026
AIML Subsidiary NeuralCloud Enters Strategic Partnership with RKS Medical Technologies to Advance CardioYield™ Clinical Pilots
September 21, 2026
AI/ML Innovations Launches Quantum Soma Initiative with Dynex Quantum Technologies for Contactless Quantum Biosensing Platform
September 1, 2026
AI/ML Innovations subsidiary NeuralCloud Appoints Former FDA Reviewer Dr. Mehmet Kosoglu as the Head of Regulatory Affairs
Founder Dispatch · Substack
A 6-part founder dispatch series on building MaxYield and the future of cardiac AI — from the inside. Honest, technical, and on the record. Published at paulduffy.substack.com.
A SUBSTACK BY PAUL DUFFY
Signal & Noise.
6-part series
PD
Paul Duffy · Executive Chairman & CEO, AI/ML Innovations Inc.
"Building the Future of Cardiac AI — from the inside. Founder dispatches from AI/ML Innovations Inc. (CSE: AIML) by serial entrepreneur Paul Duffy."
A direct line from the CEO to shareholders, partners, and the broader cardiac-AI community. Six dispatches, dropping weekly, covering the platform decisions, the regulatory grind, and the path to 2026.
LAUNCHED APRIL 2026 · 6 DISPATCHES · 1 NEW · 3,800 SUBSCRIBERS
Video · YouTube
December 23, 2025
AI/ML Innovations 2025 Shareholder Update & 2026 Roadmap Presentation
subscribe
Pick the lanes you care about and we will route press releases, monthly recaps, founder dispatches, and shareholder letters straight to your inbox.